Neuren Pharmaceuticals
NEU.AX
#5315
Rank
NZ$2.07 B
Marketcap
$15.93
Share price
0.14%
Change (1 day)
-35.87%
Change (1 year)

EPS for Neuren Pharmaceuticals (NEU.AX)

EPS in 2023: $1.49

According to Neuren Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $1.49. In 2023 the company made an earnings per share (EPS) of $1.49 an increase over its 2022 EPS that were of $0.001804.

EPS history for Neuren Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023$1.4982396.45%
2022$0.001804-102.13%
2021-$0.08458-27.64%
2020-$0.12-12.55%
2019-$0.13-446.24%
2018$0.03860-247.23%
2017-$0.02622-85.3%
2016-$0.18-13.42%
2015-$0.2134.36%
2014-$0.15-47.14%
2013-$0.2983.64%
2012-$0.16-28.56%
2011-$0.22-46.5%
2010-$0.41-3690.16%
2009$0.01151-100.76%
2008-$1.51-38.72%
2007-$2.4711.23%
2006-$2.2214.27%
2005-$1.94-42.59%
2004-$3.382.56%
2003-$3.3036.5%
2002-$2.42